Study of Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2014
At a glance
- Drugs Docetaxel (Primary) ; Oxaliplatin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 19 Jan 2012 Additional lead trial investigator (Leonard J Appleman) identified as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual patient number (34) added as reported by ClinicalTrials.gov.